Posts by: Ana Pamplona

Ana Pamplona

Ana holds her PhD in Biochemistry from the Faculty of Science and Technology from Lisbon (UNL). She has worked in the T-cell differentiation and Tumor targeting Lab at Instituto de Medicina Molecular, headed by Prof. Bruno Silva-Santos, and has served as a scientific reviewer for the peer-reviewed journal Infection & Immunity.

December 7, 2015December 7, 2015

Understanding the Role of Aryl Hydrocarbon Receptor in RA Pathogenesis

News

A new review entitled “Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis” published in the Journal of Experimental Pharmacology highlights the current knowledge about the role of aryl hydrocarbon ... Read more

October 29, 2015October 29, 2015

Moderate-to-Severe Rheumatoid Arthritis Patients May Benefit from Olokizumab

News

A new study entitled “Long-Term Safety and Efficacy of Olokizumab in Patients with Moderate-to-Severe Rheumatoid Arthritis Who Have Previously Failed Anti-TNF Treatment” will be presented during the 2015 American College of ... Read more

July 17, 2015July 17, 2015

New Subset of Human Long-Lived Plasma Cells Identified As Immune Archive

News

Researchers from Emory University identified a new group of long-lived antibody-producing cells in human bone marrow that function as an immune archive, which may carry implications for future research on ... Read more

March 17, 2015March 17, 2015

Evidence of Periodontitis in Rheumatoid Arthritis Patients

News, rheumatoid arthritis

The 93rd General Session and Exhibition of the International Association for Dental Research (IADR) was recently held in Boston, Massachusetts, between 11 and 14 of March, simultaneously with the 44th Annual ... Read more

March 16, 2015March 16, 2015

M-MDSCs Improves Arthritis in Collagen-induced Arthritis (CIA) Mouse Model

News, rheumatoid arthritis

A recent study using a mouse model of Rheumatoid Arthritis (RA) showed that cellular immunotherapy by administration of monocytic myeloid-derived suppressor cells (M-MDSCs) may be an efficient therapy for this ... Read more

February 10, 2015February 10, 2015

Chikungunya May Mislead Rheumatoid Arthritis Diagnoses

News, rheumatoid arthritis

An infection with the Chikungunya virus presents several clinical similarities with rheumatoid arthritis that may lead to inaccurate diagnoses. A new study entitled “Chikungunya viral arthritis in the United States: A mimic of ... Read more

January 28, 2015January 27, 2015

Inhibiting Lipogenesis May Help with Rheumatoid Arthritis Inflammation

News

A new study entitled “Peroxisomal Lipid Synthesis Regulates Inﬂammation by Sustaining Neutrophil Membrane Phospholipid Composition and Viability” published in Cell Metabolism by Irfan J. Lodhi part of Dr. Clay F. ... Read more

January 23, 2015January 23, 2015

Reducing Abatacept Dose in Early RA Does Not Affect Remission

News, rheumatoid arthritis

A new study on rheumatoid arthritis entitled “Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis” ... Read more

January 22, 2015January 22, 2015

Rheumatoid Arthritis Treatment and Progression Affected by Socioeconomic Status

News, rheumatoid arthritis

A Canadian study on rheumatoid arthritis (RA) revealed the influence of clinical and socioeconomic variables in the discontinuation of biologic therapy by RA patients. The study entitled “Biologic Discontinuation in ... Read more

January 16, 2015January 16, 2015

Lower Socioeconomic Status Associated With Rheumatoid Arthritis Treatment Delay, Study Shows

News, rheumatoid arthritis

A new study entitled “Association of Socioeconomic Status with Treatment Delays, Disease Activity, Joint Damage and Disability in Rheumatoid Arthritis” was published in Arthritis Care & Research by Emily Molina ... Read more